Inventor · Somerville, NJ, US

Stephane L. Bogen

47Patents
14h-index
174Co-inventors
84Inventor score

Filing activity: Jul 19, 2001 → Aug 16, 2021

Most-cited inventions

PatentTitleAreaCited byStatus
US7012066B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus Human Necessities 83 Expired
US7244721B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus Human Necessities 50 Expired
US6800434B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus Human Necessities 47 Expired
US9061041B2 2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Chemistry; Metallurgy 32 Active
US7592316B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus Human Necessities 30 Active
US6894072B2 Compounds as NS3-serine protease inhibitors of hepatitis C virus Chemistry; Metallurgy 28 Expired
US7205330B2 Inhibitors of hepatitis C virus NS3 protease Chemistry; Metallurgy 28 Expired
US9156872B2 2′-azido substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Chemistry; Metallurgy 28 Active
US7884107B2 Substituted piperidines that increase P53 activity and the uses thereof Chemistry; Metallurgy 27 Active
US7169760B2 Peptides as NS3-serine protease inhibitors of hepatitis C virus Chemistry; Metallurgy 24 Expired
US7186747B2 Compounds as inhibitors of hepatitis C virus NS3 serine protease Human Necessities 18 Expired
US7173057B2 Ketoamides with cyclic P4'S as inhibitors of NS3 protease of hepatitis C virus Chemistry; Metallurgy 16 Expired
USRE43298E1 Peptides as NS3-serine protease inhibitors of hepatitis C virus General 15 Active
US7423058B2 Inhibitors of hepatitis C virus NS3 protease Human Necessities 14 Active
US7192957B2 Compounds as inhibitors of hepatitis C virus NS3 serine protease Human Necessities 11 Expired
US9242988B2 2′-cyano substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Chemistry; Metallurgy 7 Active
US7425576B2 Compounds as inhibitors of hepatitis C virus NS3 serine protease Human Necessities 7 Active
US8067379B2 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Human Necessities 5 Active
US9150603B2 2′-cyano substituted nucleoside derivatives and methods of use thereof useful for the treatment of viral diseases Emerging Cross-Sectional Technologies 5 Active
US7816326B2 Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease Chemistry; Metallurgy 5 Active
US7619094B2 Ketoamides with cyclic P4's as inhibitors of NS3 serine protease of hepatitis C virus Chemistry; Metallurgy 4 Active
US10086000B2 Tricyclic compounds as inhibitors of mutant IDH enzymes Human Necessities 3 Active
US8859776B2 Substituted piperidines that increase p53 activity and the uses thereof Chemistry; Metallurgy 2 Active
US9416154B2 5′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseases Human Necessities 2 Active
US8962611B2 Substituted imidazopyridines as HDM2 inhibitors Chemistry; Metallurgy 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.